About Pediatric Clinical Trials
Clinical trials typically test a specific involvement which may be a drug, medical device, or procedure-- following a research protocol developed by an investigator. Children and adolescents upto 18 years as their bodies’ physiology and chemistry react very differently to illness and disease. Thus, pediatric clinical trials are critical to developing treatments and medications for childhood disease and illnesses. The number of paediatric clinical trials in EU has remarkably increased in the last decade in response to the execution of the new Paediatric Regulation and enticements aiming to define the need of child-specific drug development.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Pediatric Clinical Trials market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Bristol-Myers Squibb Company (United States), Charles River Laboratories International Inc. (United States), Covance Inc. (United States), GlaxoSmithKline plc (United Kingdom), ICON plc (Ireland), IQVIA (United States), Novartis AG (Switzerland), Pfizer, Inc. (United States), Pharmaceutical Product Development, LLC (United States), Syneos Health Inc. (United States), Parexel (United States), Duke Clinical Research Institute (United States), Syneos Health (United States), PRA Health Sciences (United States) and Chiltern (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Paidion Research, Inc. (United States) and Medpace (United States).
Segmentation Overview
AMA Research has segmented the market of Global Pediatric Clinical Trials market by Type (Phase I, Phase II, Phase III and Phase IV), Application (Respiratory Diseases, Infectious Diseases, Oncology, Diabetes and Others) and Region.
On the basis of geography, the market of Pediatric Clinical Trials has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Study Design, the sub-segment i.e. Interventional [Randomized Trial will boost the Pediatric Clinical Trials market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Implementation of Clinical Trials by Pharmaceutical Companies on Their Own Premises
Market Growth Drivers:
Growing Awareness about Pediatric Medicine and Rising Burden of Pediatric Diseases, Such as Diabetes
Challenges:
The Gap between the Number of Paediatric and Adult-Randomised Controlled Trials
Opportunities:
Shifting From In-House Clinical Research to Contract Research Organization (CRO) and Increasing Research Practices in Pharmaceutical Companies
Market Leaders and their expansionary development strategies
March 2022 - Pfizer started Phase 2/3 research in March 2022 for PAXLOVID pills, which are intended to treat COVID-19 in young patients. Within three days of the onset of symptoms, PAXLOVID decreased the probability of hospitalisation or mortality from any cause by 89% and 88%, respectively (within five days of appearance of symptoms).
March 2022 - As the first of numerous significant enhancements to its leading life science customer engagement platform, IQVIA had announced the launch of OCE+. With the addition of IQVIA's Next Best recommendation engine to its Orchestrated Customer Engagement (OCE) platform, OCE+ provides enhanced HCP experiences, higher efficiency, and increased ROI for healthcare professionals (HCPs).
The FDA released an update to the nearly two-decades old harmonized guidelines on clinical investigations in pediatric patients (originally adopted by the FDA in December 2000). The updated guidance for industry, E11(R1) Addendum: Clinical Investigation of Medicinal Products in the Pediatric Population, was issued by the FDA on April 11, 2018. Evidence for pediatric efficacy and safety is required by the FDA under the Pediatric Research Equity Act (PREA) in certain drug applications for new active ingredients, new indications, new dosage forms, new dosing regimens, or new routes of administration. and In the European Union, paediatric clinical trials are conducted under the 2007 Paediatric Regulation. This act provides the legal framework for safe research on children, ensuring that studies are high quality, ethically researched, and fully authorised.
Key Target Audience
Pediatric Clinical Trials Providers, Pharmaceutical Industry, Clinical Research Institutes, Regulatory Bodies and Governmental Bodies
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.